Professor Ben Cooper
Contact information
Podcast interview
Drug-resistant infections and disease dynamics
Infectious diseases carry a huge impact and developing interventions remains a priority. A recent trial in Southeast Asia aimed at shortening antibiotic treatment for ventilator-associated pneumonia, reducing side effects and the risk of antimicrobial resistance. Collaborations underline the global AMR burden and the need for effective solutions, from improved antibiotics use to novel diagnostics and vaccines, crucial amid rising challenges.
Ben Cooper
Professor of Epidemiology
Ben Cooper's work uses mathematical and statistical modelling, observational studies and clinical trials to help understand the burden and dynamics of infectious diseases and evaluate potential control measures. His current work focuses on drug-resistant infections and emerging pathogens. He leads the Drug-Resistant Infection and Disease Dynamics group (DRIaDD).
Recent publications
-
Waterlow NR. et al, (2024), PLoS Med, 21
-
Lydeamore MJ. et al, (2024)
-
Pritchard MG. et al, (2023)
-
Cooper BS. et al, (2023), Nature, 623, 132 - 138
-
Cavany S. et al, (2023), Nature communications, 14